Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12193750 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine;   Biological: LAG-3

Study has passed its completion date and status has not been verified in more than two years.